| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.801 | 0.004 | 0.801 | Vasodilator, coronary | 0.705 0.004 CID_161569 | ||
| 0.76 | 0.005 | 0.767 | Cardiotonic | 0.767 0.005 CID_161569 | CID_161569 | |
| 0.745 | 0.004 | 0.75 | P-glycoprotein inhibitor | 0.75 0.004 CID_161569 | CID_161569 | |
| 0.699 | 0.006 | 0.699 | Spasmolytic | 0.6 0.013 CID_161569 | ||
| 0.548 | 0.002 | 0.548 | Calcium antagonist | 0.526 0.002 CID_161569 | ||
| 0.538 | 0.004 | 0.538 | Calcium channel blocker | 0.429 0.005 CID_161569 | ||
| 0.539 | 0.009 | 0.539 | Vasodilator | 0.536 0.009 CID_161569 | ||
| 0.547 | 0.021 | 0.572 | Immunosuppressant | 0.572 0.017 CID_161569 | CID_161569 | |
| 0.531 | 0.023 | 0.531 | Vasodilator, peripheral | 0.401 0.055 CID_161569 | ||
| 0.499 | 0.008 | 0.52 | Anesthetic general | 0.52 0.007 CID_161569 | CID_161569 | |
| 0.43 | 0.006 | 0.43 | Nav1.2 sodium channel blocker | 0.392 0.007 CID_161569 | ||
| 0.427 | 0.005 | 0.427 | Anesthetic local | 0.283 0.014 CID_161569 | ||
| 0.453 | 0.049 | 0.453 | Calcium channel L-type activator | |||
| 0.4 | 0.004 | 0.4 | Nav1.6 sodium channel blocker | 0.372 0.004 CID_161569 | ||
| 0.423 | 0.041 | 0.423 | 5 Hydroxytryptamine release stimulant | 0.415 0.043 CID_161569 | ||
| 0.382 | 0.005 | 0.382 | Nav1.3 sodium channel blocker | 0.24 0.015 CID_161569 | ||
| 0.326 | 0.004 | 0.326 | Calcium channel L-type blocker | 0.242 0.004 CID_161569 | ||
| 0.327 | 0.007 | 0.327 | Nav1.1 sodium channel blocker | 0.306 0.008 CID_161569 | ||
| 0.321 | 0.003 | 0.337 | Glutamate release inhibitor | 0.337 0.003 CID_161569 | CID_161569 | |
| 0.32 | 0.005 | 0.32 | Calcium channel (voltage-sensitive) blocker | 0.226 0.013 CID_161569 | ||
| 0.349 | 0.05 | 0.349 | Calcium channel activator | 0.301 0.091 CID_161569 | ||
| 0.356 | 0.062 | 0.392 | Antithrombotic | 0.392 0.051 CID_161569 | CID_161569 | |
| 0.333 | 0.058 | 0.464 | Aldehyde oxidase inhibitor | 0.464 0.038 CID_161569 | CID_161569 | |
| 0.228 | 0.007 | 0.228 | Vanilloid 1 agonist | 0.216 0.009 CID_161569 | ||
| 0.198 | 0.005 | 0.198 | Histamine H2 receptor antagonist | 0.124 0.019 CID_161569 | ||
| 0.243 | 0.056 | 0.253 | Peptidyltransferase inhibitor | 0.253 0.049 CID_161569 | CID_161569 | |
| 0.202 | 0.027 | 0.202 | Alpha adrenoreceptor antagonist | 0.096 0.059 CID_161569 | ||
| 0.257 | 0.09 | 0.257 | Ca(v)3.3 blocker | 0.227 0.139 CID_161569 | ||
| 0.182 | 0.022 | 0.182 | Calcium channel N-type blocker | 0.131 0.051 CID_161569 | ||
| 0.161 | 0.004 | 0.161 | Potassium channel Kv1.3 blocker | 0.136 0.005 CID_161569 | ||
| 0.235 | 0.085 | 0.493 | Superoxide dismutase inhibitor | 0.493 0.013 CID_161569 | CID_161569 | |
| 0.168 | 0.018 | 0.168 | Sphingomyelinase inhibitor | 0.114 0.046 CID_161569 | ||
| 0.191 | 0.044 | 0.192 | MAP kinase kinase 5 inhibitor | 0.192 0.043 CID_161569 | CID_161569 | |
| 0.176 | 0.029 | 0.176 | Antiadrenergic | 0.116 0.047 CID_161569 | ||
| 0.165 | 0.019 | 0.186 | Multidrug resistance-associated protein 1 inhibitor | 0.186 0.014 CID_161569 | CID_161569 | |
| 0.318 | 0.175 | 0.358 | Caspase 9 stimulant | 0.358 0.139 CID_161569 | CID_161569 | |
| 0.171 | 0.029 | 0.171 | Adrenaline antagonist | 0.112 0.047 CID_161569 | ||
| 0.162 | 0.021 | 0.162 | Nav1.5 sodium channel blocker | 0.157 0.024 CID_161569 | ||
| 0.226 | 0.088 | 0.226 | Tumour necrosis factor alpha release inhibitor | 0.19 0.118 CID_161569 | ||
| 0.151 | 0.014 | 0.151 | Toll-Like receptor 3 antagonist | 0.087 0.076 CID_161569 | ||
| 0.287 | 0.151 | 0.287 | Analgesic | |||
| 0.255 | 0.124 | 0.26 | Transcription factor NF kappa B inhibitor | 0.26 0.12 CID_161569 | CID_161569 | |
| 0.149 | 0.021 | 0.184 | Protein kinase C delta inhibitor | 0.184 0.011 CID_161569 | CID_161569 | |
| 0.136 | 0.013 | 0.14 | Vanilloid agonist | 0.14 0.012 CID_161569 | CID_161569 | |
| 0.234 | 0.112 | 0.251 | Insulysin inhibitor | 0.251 0.095 CID_161569 | CID_161569 | |
| 0.128 | 0.007 | 0.128 | Estrogen-related receptor beta agonist | 0.114 0.013 CID_161569 | ||
| 0.135 | 0.017 | 0.173 | Ornithine decarboxylase inhibitor | 0.173 0.007 CID_161569 | CID_161569 | |
| 0.173 | 0.058 | 0.204 | Neurotensin receptor agonist | 0.204 0.033 CID_161569 | CID_161569 | |
| 0.141 | 0.026 | 0.141 | Electron transport complex I inhibitor | 0.131 0.035 CID_161569 | ||
| 0.159 | 0.048 | 0.159 | Adenylate cyclase stimulant | 0.156 0.053 CID_161569 | ||
| 0.156 | 0.045 | 0.164 | Farnesoid X receptor antagonist | 0.164 0.039 CID_161569 | CID_161569 | |
| 0.115 | 0.012 | 0.115 | Calcium channel T-type blocker | 0.104 0.015 CID_161569 | ||
| 0.219 | 0.118 | 0.288 | 5 Hydroxytryptamine uptake stimulant | 0.288 0.051 CID_161569 | CID_161569 | |
| 0.229 | 0.151 | 0.229 | Sodium/bile acid cotransporter inhibitor | |||
| 0.139 | 0.064 | 0.143 | Tubulin antagonist | 0.143 0.061 CID_161569 | CID_161569 | |
| 0.126 | 0.052 | 0.148 | TRPA1 agonist | 0.148 0.032 CID_161569 | CID_161569 | |
| 0.136 | 0.062 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.069 CID_161569 | ||
| 0.121 | 0.047 | 0.121 | Acetylcholine release stimulant | |||
| 0.097 | 0.024 | 0.122 | Protein kinase C alpha inhibitor | 0.122 0.015 CID_161569 | CID_161569 | |
| 0.112 | 0.039 | 0.112 | Glutamate (mGluR7) agonist | |||
| 0.127 | 0.055 | 0.127 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.147 | 0.077 | 0.147 | Acetylcholine M1 receptor antagonist | 0.147 0.078 CID_161569 | ||
| 0.111 | 0.042 | 0.111 | Ca(v)2.2 blocker | 0.09 0.056 CID_161569 | ||
| 0.114 | 0.049 | 0.114 | Bronchodilator | 0.089 0.076 CID_161569 | ||
| 0.128 | 0.066 | 0.153 | Cathepsin H inhibitor | 0.153 0.044 CID_161569 | CID_161569 | |
| 0.169 | 0.108 | 0.171 | Platelet aggregation inhibitor | 0.171 0.106 CID_161569 | CID_161569 | |
| 0.147 | 0.086 | 0.192 | Melanin inhibitor | 0.192 0.044 CID_161569 | CID_161569 | |
| 0.198 | 0.14 | 0.248 | Tyrosine 3 hydroxylase inhibitor | 0.248 0.07 CID_161569 | CID_161569 | |
| 0.095 | 0.039 | 0.095 | Alpha 2a adrenoreceptor antagonist | |||
| 0.093 | 0.038 | 0.093 | Alpha 1b adrenoreceptor antagonist | |||
| 0.176 | 0.122 | 0.176 | ErbB-1 antagonist | |||
| 0.068 | 0.016 | 0.07 | Vanilloid 2 antagonist | 0.07 0.014 CID_161569 | CID_161569 | |
| 0.11 | 0.061 | 0.11 | Falcipain 3 inhibitor | |||
| 0.186 | 0.146 | 0.235 | Neuropeptide Y2 antagonist | 0.235 0.071 CID_161569 | CID_161569 | |
| 0.05 | 0.01 | 0.05 | Melatonin 1 agonist | 0.034 0.021 CID_161569 | ||
| 0.067 | 0.027 | 0.076 | Protein kinase C theta inhibitor | 0.076 0.017 CID_161569 | CID_161569 | |
| 0.06 | 0.021 | 0.06 | Squalene epoxidase inhibitor | 0.052 0.03 CID_161569 | ||
| 0.086 | 0.049 | 0.086 | Alpha 1 adrenoreceptor antagonist | |||
| 0.07 | 0.034 | 0.07 | Adrenaline uptake inhibitor | |||
| 0.089 | 0.056 | 0.089 | Alpha 2 adrenoreceptor antagonist | |||
| 0.198 | 0.166 | 0.199 | Cholesterol antagonist | 0.199 0.165 CID_161569 | CID_161569 | |
| 0.122 | 0.091 | 0.17 | Protein kinase stimulant | 0.17 0.055 CID_161569 | CID_161569 | |
| 0.093 | 0.063 | 0.101 | Prolactin inhibitor | 0.101 0.054 CID_161569 | CID_161569 | |
| 0.086 | 0.055 | 0.086 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.141 | 0.112 | 0.157 | Tumour necrosis factor antagonist | 0.157 0.092 CID_161569 | CID_161569 | |
| 0.042 | 0.013 | 0.042 | Melatonin agonist | |||
| 0.064 | 0.038 | 0.064 | Beta tubulin antagonist | |||
| 0.051 | 0.025 | 0.051 | Benzodiazepine antagonist | |||
| 0.065 | 0.042 | 0.065 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.115 | 0.097 | 0.124 | Histone deacetylase SIRT1 inhibitor | 0.124 0.087 CID_161569 | CID_161569 | |
| 0.143 | 0.127 | 0.18 | Succinate dehydrogenase inhibitor | 0.18 0.068 CID_161569 | CID_161569 | |
| 0.099 | 0.085 | 0.099 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.078 | 0.066 | 0.078 | Inducible nitric-oxide synthase inhibitor | 0.078 0.066 CID_161569 | ||
| 0.109 | 0.098 | 0.109 | Sodium channel (voltage-gated) blocker | |||
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.108 | 0.1 | 0.108 | Sodium channel blocker | |||
| 0.055 | 0.047 | 0.055 | Bombesin 1 receptor agonist | |||
| 0.137 | 0.129 | 0.137 | Psychostimulant | |||
| 0.105 | 0.097 | 0.173 | Toll-Like receptor 2 antagonist | 0.173 0.038 CID_161569 | CID_161569 | |
| 0.061 | 0.056 | 0.065 | Calcium channel P-type blocker | 0.065 0.04 CID_161569 | CID_161569 | |
| 0.137 | 0.135 | 0.205 | Phospholipase C inhibitor | 0.205 0.041 CID_161569 | CID_161569 | |
| 0.031 | 0.03 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.143 | 0.153 | 0.196 | Platelet antagonist | 0.196 0.104 CID_161569 | CID_161569 | |
| 0.137 | 0.147 | 0.152 | Anticonvulsant | 0.152 0.127 CID_161569 | CID_161569 | |
| 0.023 | 0.035 | 0.028 | Dipeptidyl peptidase I inhibitor | 0.028 0.024 CID_161569 | CID_161569 | |
| 0.121 | 0.134 | 0.135 | Amyloid beta aggregation inhibitor | 0.135 0.12 CID_161569 | CID_161569 | |
| 0.129 | 0.148 | 0.192 | Antimitotic | 0.192 0.089 CID_161569 | CID_161569 | |
| 0.031 | 0.052 | 0.046 | Neurokinin 2 agonist | 0.046 0.023 CID_161569 | CID_161569 | |
| 0.137 | 0.163 | 0.156 | Free radical scavenger | 0.156 0.138 CID_161569 | CID_161569 | |
| 0.031 | 0.058 | 0.041 | Neurotensin receptor antagonist | 0.041 0.036 CID_161569 | CID_161569 | |
| 0.075 | 0.105 | 0.111 | Expectorant | 0.111 0.058 CID_161569 | CID_161569 | |
| 0.133 | 0.171 | 0.221 | Immunostimulant | 0.221 0.108 CID_161569 | CID_161569 | |
| 0.136 | 0.184 | 0.157 | Antioxidant | 0.157 0.156 CID_161569 | CID_161569 | |
| 0.083 | 0.135 | 0.139 | Cyclooxygenase 3 inhibitor | 0.139 0.058 CID_161569 | CID_161569 | |
| 0.177 | 0.232 | 0.303 | Interleukin 2 agonist | 0.303 0.071 CID_161569 | CID_161569 | |
| 0.062 | 0.12 | 0.081 | Factor XII inhibitor | 0.081 0.065 CID_161569 | CID_161569 | |
| 0.102 | 0.163 | 0.126 | Thiol protease inhibitor | 0.126 0.105 CID_161569 | CID_161569 | |
| 0.066 | 0.129 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.073 CID_161569 | CID_161569 | |
| 0.07 | 0.14 | 0.106 | Mucolytic | 0.106 0.069 CID_161569 | CID_161569 | |
| 0.055 | 0.143 | 0.094 | GABA B receptor agonist | 0.094 0.022 CID_161569 | CID_161569 | |
| 0.091 | 0.192 | 0.225 | Growth hormone agonist | 0.225 0.05 CID_161569 | CID_161569 | |
| 0.116 | 0.219 | 0.133 | Heat shock protein 70 antagonist | 0.133 0.107 CID_161569 | CID_161569 | |
| 0.059 | 0.178 | 0.113 | GABA C receptor antagonist | 0.113 0.06 CID_161569 | CID_161569 | |
| 0.098 | 0.217 | 0.194 | Interleukin agonist | 0.194 0.126 CID_161569 | CID_161569 | |
| 0.042 | 0.172 | 0.097 | Aminopeptidase B inhibitor | 0.097 0.067 CID_161569 | CID_161569 | |
| 0.087 | 0.218 | 0.138 | Hemostatic | 0.138 0.084 CID_161569 | CID_161569 | |
| 0.059 | 0.194 | 0.102 | Carbonic anhydrase XV inhibitor | 0.102 0.064 CID_161569 | CID_161569 | |
| 0.069 | 0.211 | 0.164 | Angiogenesis stimulant | 0.164 0.114 CID_161569 | CID_161569 | |
| 0.058 | 0.2 | 0.111 | Nav1.4 sodium channel blocker | 0.111 0.061 CID_161569 | CID_161569 | |
| 0.036 | 0.185 | 0.081 | GABA aminotransferase inhibitor | 0.081 0.045 CID_161569 | CID_161569 | |
| 0.008 | 0.163 | 0.048 | Kinesin-like protein 1 inhibitor | 0.048 0.017 CID_161569 | CID_161569 | |
| 0.008 | 0.163 | 0.048 | Kinesin antagonist | 0.048 0.017 CID_161569 | CID_161569 | |
| 0.115 | 0.286 | 0.188 | Transcription factor STAT3 inhibitor | 0.188 0.152 CID_161569 | CID_161569 | |
| 0.033 | 0.218 | 0.088 | Somatostatin 1 agonist | 0.088 0.043 CID_161569 | CID_161569 | |
| 0.034 | 0.253 | 0.082 | Glycine receptor agonist | 0.082 0.036 CID_161569 | CID_161569 | |
| 0.038 | 0.291 | 0.136 | Thrombolytic | 0.136 0.093 CID_161569 | CID_161569 | |
| 0.056 | 0.321 | 0.167 | Interleukin antagonist | 0.167 0.106 CID_161569 | CID_161569 | |
| 0.031 | 0.309 | 0.105 | GABA C receptor agonist | 0.105 0.061 CID_161569 | CID_161569 | |
| 0.062 | 0.508 | 0.145 | Death-associated protein kinase 2 inhibitor | 0.145 0.119 CID_161569 | CID_161569 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |